about
Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challengesProteomics portrait of archival lesions of chronic pancreatitisQuantitative proteomics of complex mixtures.Proteomics in pancreatic cancer research.Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia.Quantitative proteomic analyses of influenza virus-infected cultured human lung cells.Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells.Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma.Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.Proteomics analysis of bodily fluids in pancreatic cancerMass spectrometry based targeted protein quantification: methods and applications.Pancreatic cancer biomarkers and their implication in cancer diagnosis and epidemiology.Quantitative proteomics investigation of pancreatic intraepithelial neoplasiaScreening technologies for target identification in pancreatic cancer.Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells.Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma and originates from pancreatic islets.Pilot study of blood biomarker candidates for detection of pancreatic cancer.
P2860
Q26824034-A3791179-817C-4ED3-8EE9-4C37D10DEA36Q28478126-D21B05EA-77F3-4D86-AF9D-852BCFD6FCC7Q31039257-ED89B1A4-13F9-4599-B5DD-8A8DD6888621Q33791981-27058116-C497-4297-B24C-048A2009A700Q33944966-16888144-D513-4CCB-BFFE-AFD44991A5AEQ34178389-28A81E00-3E04-4955-A222-AFDE87FED96CQ34390304-325E1E2B-D7AE-455E-BD5B-695402A8EBC4Q34444417-01CEA3A5-77FA-4FB3-AF52-E0D0D0AA74BEQ34644418-9E0B93A7-BDD8-4B69-ABB6-44BF8F157246Q34958895-1900D45A-F11D-4CE7-852A-794816BECE7CQ35920900-C89D8ADD-62EB-4DAA-9136-7C97CE62E2A5Q37134146-392D4BF4-4D60-45C2-B35E-F5512B221781Q37342746-A2E65667-7CFB-41EF-BD3F-1142FAEDA5B3Q37416043-0A4983C3-30C4-488C-B216-6674B8EA6BAFQ38161327-A1D8D37D-44F0-4608-BC74-8CECDB56E533Q39448621-6EC5338E-B0E7-41B5-ACE6-EC63620FBD05Q39643742-6019741D-60E6-451F-BDCA-E2C1026A97E0Q40798938-84A41393-C4EA-4224-BDC1-8907422B4771
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Proteomics studies of pancreatic cancer
@ast
Proteomics studies of pancreatic cancer
@en
type
label
Proteomics studies of pancreatic cancer
@ast
Proteomics studies of pancreatic cancer
@en
prefLabel
Proteomics studies of pancreatic cancer
@ast
Proteomics studies of pancreatic cancer
@en
P2093
P2860
P356
P1476
Proteomics studies of pancreatic cancer
@en
P2093
Teresa A Brentnall
P2860
P304
P356
10.1002/PRCA.200700414
P577
2007-01-01T00:00:00Z